Dmp1m1Btlr/Dmp1m1Btlr Ptpn11m1Btlr/Ptpn11m1Btlr Sdad1m1Btlr/Sdad1m1Btlr
C57BL/6J-Dmp1m1Btlr Sdad1m1Btlr Ptpn11m1Btlr/Btlr
|
decreased bone mineral density |
J:309727
|
short tibia |
J:309727
|
Egfrwa2/Egfrwa2 Ptpn11tm1Paw/Ptpn11+
involves: 129S1/Sv * 129X1/SvJ * B6EiC3Sn a/A-Egfrwa2 Wnt3avt * C57BL/6
|
abnormal breathing pattern |
J:75413
|
abnormal hair follicle development |
J:75413
|
abnormal hair follicle morphology |
J:75413
|
abnormal hair follicle orientation |
J:75413
|
abnormal hair growth |
J:75413
|
abnormal intestine morphology |
J:75413
|
abnormal lung development |
J:75413
|
abnormal muscle morphology |
J:75413
|
abnormal skin condition |
J:75413
|
atelectasis |
J:75413
|
cachexia |
J:75413
|
decreased hair follicle number |
J:75413
|
decreased subcutaneous adipose tissue amount |
J:75413
|
dry skin |
J:75413
|
epidermal atrophy |
J:75413
|
eyelids open at birth |
J:75413
|
flaky skin |
J:75413
|
intestinal hypoperistalsis |
J:75413
|
postnatal growth retardation |
J:75413
|
postnatal lethality, incomplete penetrance |
J:75413
|
thick pulmonary interalveolar septum |
J:75413
|
thin epidermis |
J:75413
|
thin skin |
J:75413
|
waved hair |
J:75413
|
Egfrwa2/Egfrwa2 Ptpn11tm1Rbn/Ptpn11+
involves: 129 * B6EiC3Sn-a/A-Egfrwa2 Wnt3avt
|
abnormal impulse conducting system conduction |
J:60750
|
aortic valve regurgitation |
J:60750
|
aortic valve stenosis |
J:60750
|
congestive heart failure |
J:60750
|
enlarged semilunar valve |
J:60750
|
eyelids open at birth |
J:60750
|
increased left ventricle diastolic pressure |
J:60750
|
increased left ventricle systolic pressure |
J:60750
|
increased systemic arterial blood pressure |
J:60750
|
myocardium hypertrophy |
J:60750
|
perinatal lethality, incomplete penetrance |
J:60750
|
prolonged PR interval |
J:60750
|
prolonged QRS complex duration |
J:60750
|
prolonged QT interval |
J:60750
|
prolonged RR interval |
J:60750
|
prolonged ST segment |
J:60750
|
thick aortic valve |
J:60750
|
thick pulmonary valve |
J:60750
|
Egr2tm2(cre)Pch/Egr2+ Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/? Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6
|
abnormal myelination |
J:207470
|
Egr2tm2(cre)Pch/Egr2+ Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky/? Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6
|
hypermyelination |
J:207470
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+ Ptpn11tm1.1Rbns/Ptpn11tm1.1Rbns H2az2Tg(Wnt1-cre)11Rth/H2az2+
B6.Cg-Ptpn11tm1.1Rbns Gt(ROSA)26Sortm1Sor H2az2Tg(Wnt1-cre)11Rth
|
decreased cardiac neural crest cell number |
J:150835
|
impaired cranial neural crest cell differentiation |
J:150835
|
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/? Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm Tg(Dhh-cre)1Mejr/0
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
|
abnormal myelination |
J:207470
|
Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky/? Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm Tg(Dhh-cre)1Mejr/0
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
|
hypermyelination |
J:207470
|
Krastm4Tyj/Krastm4Tyj Ptpn11tm1Gsf/Ptpn11tm1Gsf Tg(Six3-cre)69Frty/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2
|
abnormal cone electrophysiology |
J:174095
|
abnormal rod electrophysiology |
J:174095
|
decreased a-wave amplitude |
J:174095
|
decreased b-wave amplitude |
J:174095
|
normal
vision/eye phenotype |
J:174095
|
Mapk1tm1Melo/Mapk1+ Tg(Myh7-Ptpn11*Q79R)11Rbns/0
involves: 129S2/SvPas * FVB/N
|
normal
cardiovascular system phenotype |
J:123963
|
normal
respiratory system phenotype |
J:123963
|
Mapk3tm1Gpg/Mapk3tm1Gpg Tg(Myh7-Ptpn11*Q79R)11Rbns/0
involves: 129/Sv * FVB/N
|
normal
cardiovascular system phenotype |
J:123963
|
normal
respiratory system phenotype |
J:123963
|
Mpzl1em1Ambt/Mpzl1em1Ambt Ptpn11tm4.2Bgn/Ptpn11tm4.2Bgn
B6.Cg-Mpzl1em1Ambt Ptpn11tm4.2Bgn
|
normal
cardiovascular system phenotype |
J:301775
|
normal
growth/size/body region phenotype |
J:301775
|
slow postnatal weight gain |
J:301775
|
Ptentm1Hwu/Ptentm1Hwu Ptpn11tm1Gsf/Ptpn11tm1Gsf Tg(Six3-cre)69Frty/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2
|
optic nerve atrophy |
J:174095
|
retina degeneration |
J:174095
|
retina ganglion cell degeneration |
J:174095
|
retina outer nuclear layer degeneration |
J:174095
|
thin retina ganglion layer |
J:174095
|
thin retina inner nuclear layer |
J:174095
|
thin retina outer nuclear layer |
J:174095
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Stat3tm1Vpo/Stat3tm1Vpo Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA
|
increased circulating alanine transaminase level |
J:172422
|
increased incidence of tumors by chemical induction |
J:172422
|
liver inflammation |
J:172422
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Stat3tm1Xyfu/Stat3tm1Xyfu Tg(Six3-cre)69Frty/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2
|
retina degeneration |
J:174095
|
retina ganglion cell degeneration |
J:174095
|
retina outer nuclear layer degeneration |
J:174095
|
thin retina ganglion layer |
J:174095
|
thin retina inner nuclear layer |
J:174095
|
thin retina outer nuclear layer |
J:174095
|
thin retina outer plexiform layer |
J:174095
|
Tg(CAG-cat,-Ptpn11)1Rbns/0 Tg(Tek-cre)12Flv/0
involves: C3H * C57BL/6 * FVB/N
|
normal
cardiovascular system phenotype |
J:142212
|
Tg(Myh6-Ptpn11)75Rbns/0
FVB.Cg-Tg(Myh6-Ptpn11)75Rbns
|
normal
cardiovascular system phenotype |
J:123963
|
Tg(Myh6-Ptpn11*Q79R)197Rbns/0
FVB.Cg-Tg(Myh6-Ptpn11*Q79R)197Rbns
|
normal
cardiovascular system phenotype |
J:123963
|
Tg(Myh6-Ptpn11*Q510E)#Krnz/0
FVB/N-Tg(Myh6-Ptpn11*Q510E)#Krnz
|
normal
cardiovascular system phenotype |
J:181656
|
Tg(Myh7-Ptpn11)294Rbns/0
FVB.Cg-Tg(Myh7-Ptpn11)294Rbns
|
normal
cardiovascular system phenotype |
J:123963
|
Tg(Myh7-Ptpn11*Q79R)11Rbns/0
FVB.Cg-Tg(Myh7-Ptpn11*Q79R)11Rbns
|
abnormal atrial thrombosis |
J:123963
|
abnormal cardiovascular system physiology |
J:123963
|
abnormal interventricular groove morphology |
J:123963
|
decreased cardiac muscle contractility |
J:123963
|
dilated heart atrium |
J:123963
|
dilated heart ventricle |
J:123963
|
increased heart weight |
J:123963
|
increased lung weight |
J:123963
|
premature death |
J:123963
|
thick ventricular wall |
J:123963
|
ventricular cardiomyopathy |
J:123963
|
ventricular septal defect |
J:123963
|
Tg(Myh7-Ptpn11*Q510E)#Krnz/0
FVB/N-Tg(Myh7-Ptpn11*Q510E)#Krnz
|
abnormal fetal cardiomyocyte morphology |
J:181656
|
abnormal heart echocardiography feature |
J:181656,
J:222124
|
abnormal heart morphology |
J:181656
|
abnormal heart ventricle shape |
J:181656
|
abnormal interventricular groove morphology |
J:181656
|
abnormal myocardial fiber morphology |
J:222124
|
abnormal myocardial fiber physiology |
J:222124
|
cardiac hypertrophy |
J:181656,
J:222124
|
cardiac interstitial fibrosis |
J:181656
|
cardiomyopathy |
J:181656
|
decreased cardiac muscle contractility |
J:181656
|
increased cardiac muscle contractility |
J:222124
|
increased heart atrium size |
J:181656
|
increased heart left atrium size |
J:181656
|
increased heart weight |
J:181656,
J:222124
|
increased myocardial fiber size |
J:181656,
J:222124
|
thick interventricular septum |
J:181656
|
ventricular septal defect |
J:181656
|